Register entry
- Registered sites
- 0
- Active NDC listings
- 8
- Labeller names
- 2
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
88 active NDC listings: 8 human prescription drug. By marketing category: ANDA 6, NDA 2.
| Dosage form | NDCs |
|---|---|
| capsule | 6 |
| capsule, extended release | 2 |
| Route | NDCs |
|---|---|
| oral | 8 |
| Labeller name on the listing | NDCs |
|---|---|
| opko pharmaceuticals, llc | 6 |
| opko pharmaceuticals llc | 2 |
Catalogue
Marketed products
8| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Cyclophosphamide | CYCLOPHOSPHAMIDE | capsule, oral | 70301-2013ANDA |
| Cyclophosphamide | CYCLOPHOSPHAMIDE | capsule, oral | 70301-2015ANDA |
| Rayaldee | calcifediol | capsule, extended release, oral | 70301-1001NDA |
| Rayaldee | calcifediol | capsule, extended release, oral | 70301-1002NDA |
| Temozolomide | TEMOZOLOMIDE | capsule, oral | 70301-2005ANDA |
| Temozolomide | TEMOZOLOMIDE | capsule, oral | 70301-2007ANDA |
| Temozolomide | TEMOZOLOMIDE | capsule, oral | 70301-2009ANDA |
| Temozolomide | TEMOZOLOMIDE | capsule, oral | 70301-2011ANDA |
Compare
Other companies listing temozolomide
- Pacific Medical Industries Ltd4 sites · 41 NDC
- SHILPA PHARMA LIFESCIENCES LIMITED2 sites · 40 NDC
- Camber Pharmaceuticals, Inc.1 site · 640 NDC
- Valary Lab Private Limited1 site · 32 NDC
Enquiry
Common questions
- Is OPKO Pharmaceuticals, LLC FDA approved?
- OPKO Pharmaceuticals, LLC holds no registered establishment of its own; 8 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does OPKO Pharmaceuticals, LLC make?
- 8 products are listed under OPKO Pharmaceuticals, LLC in the openFDA NDC Directory, most often as capsule; capsule, extended release. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.